Restructuring Delivered Greater-Than-Expected Benefit
Completed 2024–2025 restructuring with ~ $63 million of EBIT benefit flowing in 2025 and an expected ~$5 million in 2026 for a ~$70 million EBIT run-rate; total restructuring cost ~ $80 million (about half noncash).
Balance Sheet Strengthened and Deleveraging Progress
Used Aerospace divestiture proceeds, cash from operations and real estate sales to reduce debt by $376 million in 2025; net debt to adjusted EBITDA improved from 3.8x to 2.4x, moving meaningfully closer to 2.0x target.
Improved Cash Generation and Working Capital
Operating cash flow was $338 million in 2025, up $33 million versus 2024; adjusted working capital was 11.6% of annualized sales, down 140 basis points year-over-year; company expects to prioritize net debt reduction with excess cash flow in 2026.
Q4 and Full-Year Adjusted Earnings Performance
Fourth quarter adjusted EBIT was $48 million and adjusted EPS was $0.22 (up 5% vs. Q4 2024 adjusted EPS $0.21). Full-year adjusted EBIT was $263 million (down $4 million vs. 2024) and adjusted EPS was $1.05, essentially flat year-over-year.
Portfolio Simplification and Strategic Progress
Divested Aerospace in Q3 2025; progress in semi-finished bedding products (Eco-Base, pre-foam-encased ComfortCore), Specialty Foam customer diversification, Automotive innovation pipeline, launch of Home Furniture facility in Vietnam, and expansion into medical nonwovens and retail growth for Geo Components.
Guidance Reflects Focus on Margin and Efficiency
2026 adjusted EPS guided to $1.00–$1.20 and adjusted EBIT margin guided to 6.3%–7.0%; company expects inflation and currency to add low-single-digit sales benefit and plans to reinvest and pursue small strategic acquisitions while prioritizing deleveraging.
Real Estate and Other One-Time Cash Benefits
Expect $70–$80 million of real estate sale proceeds (about $48 million realized in 2025) and a projected $0.11–$0.25 per share gain from real estate in 2026 guidance assumptions.